Neogen Chemicals Ltd
NSE:NEOGEN
Neogen Chemicals Ltd
NSE:NEOGEN
Price:
1 388.4
INR
1.68%
Market Cap:
₹36.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neogen Chemicals Ltd
NSE:NEOGEN
|
IN |
|
Pactiv Evergreen Inc
F:PEG
|
US |
|
F
|
Future Market Networks Ltd
NSE:FMNL
|
IN |
|
S
|
Shanghai OPM Biosciences Co Ltd
SSE:688293
|
CN |
|
G
|
General Dynamics Corp
XETRA:GDX
|
US |
|
C
|
CPM Group Ltd
HKEX:1932
|
HK |
Income Statement
Earnings Waterfall
Neogen Chemicals Ltd
Neogen Chemicals Ltd
Income Statement
Neogen Chemicals Ltd
Neogen Chemicals Ltd
Currency: INR
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
110
|
0
|
0
|
0
|
129
|
0
|
0
|
0
|
178
|
0
|
0
|
0
|
237
|
0
|
0
|
0
|
378
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
2 391
N/A
|
2 648
+11%
|
2 846
+7%
|
3 037
+7%
|
3 061
+1%
|
3 183
+4%
|
3 231
+2%
|
3 260
+1%
|
3 364
+3%
|
3 445
+2%
|
3 757
+9%
|
4 232
+13%
|
4 873
+15%
|
5 505
+13%
|
5 855
+6%
|
6 391
+9%
|
6 862
+7%
|
7 032
+2%
|
7 168
+2%
|
6 950
-3%
|
6 907
-1%
|
7 058
+2%
|
7 374
+4%
|
7 744
+5%
|
7 776
+0%
|
7 843
+1%
|
7 996
+2%
|
8 182
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(1 407)
|
(1 645)
|
(1 788)
|
(1 812)
|
(2 180)
|
(1 933)
|
(1 940)
|
(1 949)
|
(2 394)
|
(1 967)
|
(2 129)
|
(2 372)
|
(3 428)
|
(3 102)
|
(3 249)
|
(3 565)
|
(4 867)
|
(3 987)
|
(4 074)
|
(3 926)
|
(4 517)
|
(3 870)
|
(4 093)
|
(4 276)
|
(4 992)
|
(4 284)
|
(4 301)
|
(4 372)
|
|
| Gross Profit |
984
N/A
|
1 002
+2%
|
1 057
+6%
|
1 225
+16%
|
881
-28%
|
1 250
+42%
|
1 291
+3%
|
1 311
+2%
|
970
-26%
|
1 477
+52%
|
1 628
+10%
|
1 860
+14%
|
1 445
-22%
|
2 404
+66%
|
2 606
+8%
|
2 826
+8%
|
1 995
-29%
|
3 045
+53%
|
3 094
+2%
|
3 023
-2%
|
2 390
-21%
|
3 187
+33%
|
3 281
+3%
|
3 468
+6%
|
2 783
-20%
|
3 559
+28%
|
3 695
+4%
|
3 811
+3%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(578)
|
(564)
|
(578)
|
(682)
|
(353)
|
(708)
|
(747)
|
(762)
|
(395)
|
(885)
|
(990)
|
(1 172)
|
(696)
|
(1 585)
|
(1 766)
|
(1 926)
|
(1 041)
|
(2 073)
|
(2 124)
|
(2 168)
|
(1 518)
|
(2 301)
|
(2 323)
|
(2 379)
|
(1 698)
|
(2 456)
|
(2 780)
|
(2 780)
|
|
| Selling, General & Administrative |
(112)
|
(170)
|
(190)
|
(163)
|
(298)
|
(180)
|
(188)
|
(193)
|
(325)
|
(215)
|
(242)
|
(274)
|
(530)
|
(353)
|
(391)
|
(429)
|
(822)
|
(499)
|
(556)
|
(601)
|
(1 209)
|
(651)
|
(623)
|
(613)
|
(1 343)
|
(684)
|
(779)
|
(882)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(47)
|
0
|
0
|
0
|
(57)
|
0
|
0
|
0
|
(35)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(28)
|
(32)
|
(38)
|
(43)
|
(52)
|
(59)
|
(63)
|
(68)
|
(69)
|
(72)
|
(78)
|
(97)
|
(117)
|
(137)
|
(153)
|
(157)
|
(162)
|
(178)
|
(197)
|
(213)
|
(229)
|
(242)
|
(255)
|
(269)
|
(278)
|
(268)
|
(270)
|
(267)
|
|
| Other Operating Expenses |
(438)
|
(363)
|
(350)
|
(477)
|
(3)
|
(469)
|
(495)
|
(501)
|
(1)
|
(598)
|
(671)
|
(801)
|
(2)
|
(1 095)
|
(1 222)
|
(1 340)
|
(1)
|
(1 396)
|
(1 371)
|
(1 354)
|
(45)
|
(1 408)
|
(1 444)
|
(1 497)
|
(66)
|
(1 505)
|
(1 732)
|
(1 631)
|
|
| Operating Income |
406
N/A
|
438
+8%
|
480
+10%
|
543
+13%
|
528
-3%
|
542
+3%
|
544
+0%
|
549
+1%
|
575
+5%
|
593
+3%
|
637
+8%
|
687
+8%
|
749
+9%
|
819
+9%
|
841
+3%
|
900
+7%
|
954
+6%
|
973
+2%
|
970
0%
|
856
-12%
|
872
+2%
|
886
+2%
|
959
+8%
|
1 089
+14%
|
1 085
0%
|
1 103
+2%
|
915
-17%
|
1 031
+13%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
(119)
|
(109)
|
(106)
|
(125)
|
(108)
|
(119)
|
(128)
|
(128)
|
(125)
|
(137)
|
(142)
|
(174)
|
(167)
|
(214)
|
(242)
|
(245)
|
(198)
|
(335)
|
(378)
|
(415)
|
(303)
|
(409)
|
(426)
|
(455)
|
(361)
|
(511)
|
(578)
|
(659)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(141)
|
(141)
|
0
|
(141)
|
|
| Total Other Income |
7
|
2
|
0
|
3
|
(10)
|
1
|
1
|
1
|
(8)
|
1
|
2
|
2
|
(12)
|
19
|
22
|
36
|
(46)
|
53
|
68
|
70
|
(41)
|
73
|
62
|
56
|
(82)
|
36
|
47
|
58
|
|
| Pre-Tax Income |
293
N/A
|
331
+13%
|
375
+13%
|
422
+13%
|
411
-3%
|
424
+3%
|
418
-2%
|
422
+1%
|
442
+5%
|
457
+3%
|
498
+9%
|
516
+4%
|
571
+11%
|
624
+9%
|
621
-1%
|
691
+11%
|
710
+3%
|
691
-3%
|
660
-4%
|
510
-23%
|
528
+3%
|
549
+4%
|
594
+8%
|
690
+16%
|
502
-27%
|
487
-3%
|
384
-21%
|
289
-25%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(83)
|
(95)
|
(112)
|
(120)
|
(124)
|
(131)
|
(128)
|
(129)
|
(129)
|
(131)
|
(134)
|
(133)
|
(124)
|
(141)
|
(150)
|
(178)
|
(211)
|
(204)
|
(194)
|
(180)
|
(171)
|
(175)
|
(190)
|
(196)
|
(153)
|
(151)
|
(123)
|
(92)
|
|
| Income from Continuing Operations |
210
|
236
|
263
|
302
|
287
|
293
|
290
|
293
|
313
|
326
|
364
|
383
|
446
|
484
|
471
|
513
|
500
|
486
|
467
|
331
|
357
|
374
|
404
|
494
|
348
|
336
|
261
|
197
|
|
| Net Income (Common) |
210
N/A
|
236
+12%
|
263
+11%
|
302
+15%
|
287
-5%
|
293
+2%
|
290
-1%
|
293
+1%
|
313
+7%
|
326
+4%
|
364
+12%
|
383
+5%
|
446
+17%
|
484
+8%
|
471
-3%
|
513
+9%
|
500
-3%
|
486
-3%
|
467
-4%
|
331
-29%
|
357
+8%
|
374
+5%
|
404
+8%
|
494
+22%
|
348
-29%
|
336
-3%
|
261
-23%
|
197
-24%
|
|
| EPS (Diluted) |
10.48
N/A
|
9.88
-6%
|
10.96
+11%
|
12.94
+18%
|
12.3
-5%
|
12.58
+2%
|
12.39
-2%
|
12.57
+1%
|
13.43
+7%
|
13.93
+4%
|
15.59
+12%
|
16.44
+5%
|
17.9
+9%
|
19.39
+8%
|
18.83
-3%
|
20.56
+9%
|
20.04
-3%
|
19.55
-2%
|
18.68
-4%
|
12.78
-32%
|
13.96
+9%
|
14.17
+2%
|
15.3
+8%
|
18.74
+22%
|
13.2
-30%
|
12.75
-3%
|
9.88
-23%
|
7.48
-24%
|
|
Switch to:
Switch to:
See Also
Discover More
